月経前不快気分障害（PMDD）のグローバル市場：規模・現状・予測2019-2025

• 英文タイトル：Global Premenstrual Dysphoric Disorder (PMDD) Market Size, Status and Forecast 2019-2025

• レポートコード：QYR9NV18309
• 出版社/出版日：QYResearch / 2019年11月18日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、94ページ
• 納品方法：Eメール（受注後2-3営業日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Enterprise License	￥1,170,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

※当調査レポートでは、月経前不快気分障害（PMDD）の世界市場について調査・分析し、月経前不快気分障害（PMDD）の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（テーブル製品、インジェクト製品、その他）、用途別（病院、診療所、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。

・レポートの概要
・世界の月経前不快気分障害（PMDD）市場動向
・主要企業別マーケットシェア
・月経前不快気分障害（PMDD）の種類別市場規模2014-2019
（テーブル製品、インジェクト製品、その他）
・月経前不快気分障害（PMDD）の用途別市場規模2014-2019
（病院、診療所、その他）
・月経前不快気分障害（PMDD）の北米市場：主要企業・種類別/用途別市場規模
・月経前不快気分障害（PMDD）のヨーロッパ市場：主要企業・種類別/用途別市場規模
・月経前不快気分障害（PMDD）の中国市場：主要企業・種類別/用途別市場規模
・月経前不快気分障害（PMDD）の日本国内市場：主要企業・種類別/用途別市場規模
・月経前不快気分障害（PMDD）の東南アジア市場：主要企業・種類別/用途別市場規模
・月経前不快気分障害（PMDD）のインド市場：主要企業・種類別/用途別市場規模
・月経前不快気分障害（PMDD）の中南米市場：主要企業・種類別/用途別市場規模
・主要企業のプロフィール
（Teva、Eli Liliy、Pfizer、Bayer、GSK、Apotex、Bristol Laboratories、Mylan、Allergan）
・月経前不快気分障害（PMDD）の市場規模予測2019-2025
（種類別、用途別、地域別市場予測）
・アナリストの観点・結論
...

Premenstrual dysphoric disorder (PMDD) is a health problem that is similar to premenstrual syndrome (PMS) but is more serious. PMDD causes severe irritability, depression, or anxiety in the week or two before your period starts. Symptoms usually go away two to three days after your period starts.In 2018, the global Premenstrual Dysphoric Disorder (PMDD) market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Premenstrual Dysphoric Disorder (PMDD) status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Premenstrual Dysphoric Disorder (PMDD) development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study
Teva
Eli Liliy
Pfizer
Bayer
GSK
Apotex
Bristol Laboratories
Mylan
Allergan

Market segment by Type, the product can be split into
Table Product
Inject Product
Others

Market segment by Application, split into
Hospital
Clinic
Others

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Premenstrual Dysphoric Disorder (PMDD) status, future forecast, growth opportunity, key market and key players.
To present the Premenstrual Dysphoric Disorder (PMDD) development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Premenstrual Dysphoric Disorder (PMDD) are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

レポート目次

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Premenstrual Dysphoric Disorder (PMDD) Market Size Growth Rate by Type (2014-2025)
1.4.2 Table Product
1.4.3 Inject Product
1.4.4 Others
1.5 Market by Application
1.5.1 Global Premenstrual Dysphoric Disorder (PMDD) Market Share by Application (2019-2025)
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Premenstrual Dysphoric Disorder (PMDD) Market Size
2.2 Premenstrual Dysphoric Disorder (PMDD) Growth Trends by Regions
2.2.1 Premenstrual Dysphoric Disorder (PMDD) Market Size by Regions (2019-2025)
2.2.2 Premenstrual Dysphoric Disorder (PMDD) Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis

3 Market Share by Key Players
3.1 Premenstrual Dysphoric Disorder (PMDD) Market Size by by Players
3.1.1 Global Premenstrual Dysphoric Disorder (PMDD) Revenue by by Players (2014-2019)
3.1.2 Global Premenstrual Dysphoric Disorder (PMDD) Revenue Market Share by by Players (2014-2019)
3.1.3 Global Premenstrual Dysphoric Disorder (PMDD) Market Concentration Ratio (CR5 and HHI)
3.2 Premenstrual Dysphoric Disorder (PMDD) Key Players Head office and Area Served
3.3 Key Players Premenstrual Dysphoric Disorder (PMDD) Product/Solution/Service
3.4 Date of Enter into Premenstrual Dysphoric Disorder (PMDD) Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Premenstrual Dysphoric Disorder (PMDD) Market Size by Type (2014-2019)
4.2 Global Premenstrual Dysphoric Disorder (PMDD) Market Size by Application (2014-2019)

5 North America
5.1 North America Premenstrual Dysphoric Disorder (PMDD) Market Size (2014-2019)
5.2 Premenstrual Dysphoric Disorder (PMDD) Key Players in North America
5.3 North America Premenstrual Dysphoric Disorder (PMDD) Market Size by Type
5.4 North America Premenstrual Dysphoric Disorder (PMDD) Market Size by Application

6 Europe
6.1 Europe Premenstrual Dysphoric Disorder (PMDD) Market Size (2014-2019)
6.2 Premenstrual Dysphoric Disorder (PMDD) Key Players in Europe
6.3 Europe Premenstrual Dysphoric Disorder (PMDD) Market Size by Type
6.4 Europe Premenstrual Dysphoric Disorder (PMDD) Market Size by Application

7 China
7.1 China Premenstrual Dysphoric Disorder (PMDD) Market Size (2014-2019)
7.2 Premenstrual Dysphoric Disorder (PMDD) Key Players in China
7.3 China Premenstrual Dysphoric Disorder (PMDD) Market Size by Type
7.4 China Premenstrual Dysphoric Disorder (PMDD) Market Size by Application

8 Japan
8.1 Japan Premenstrual Dysphoric Disorder (PMDD) Market Size (2014-2019)
8.2 Premenstrual Dysphoric Disorder (PMDD) Key Players in Japan
8.3 Japan Premenstrual Dysphoric Disorder (PMDD) Market Size by Type
8.4 Japan Premenstrual Dysphoric Disorder (PMDD) Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Premenstrual Dysphoric Disorder (PMDD) Market Size (2014-2019)
9.2 Premenstrual Dysphoric Disorder (PMDD) Key Players in Southeast Asia
9.3 Southeast Asia Premenstrual Dysphoric Disorder (PMDD) Market Size by Type
9.4 Southeast Asia Premenstrual Dysphoric Disorder (PMDD) Market Size by Application

10 India
10.1 India Premenstrual Dysphoric Disorder (PMDD) Market Size (2014-2019)
10.2 Premenstrual Dysphoric Disorder (PMDD) Key Players in India
10.3 India Premenstrual Dysphoric Disorder (PMDD) Market Size by Type
10.4 India Premenstrual Dysphoric Disorder (PMDD) Market Size by Application

11 Central & South America
11.1 Central & South America Premenstrual Dysphoric Disorder (PMDD) Market Size (2014-2019)
11.2 Premenstrual Dysphoric Disorder (PMDD) Key Players in Central & South America
11.3 Central & South America Premenstrual Dysphoric Disorder (PMDD) Market Size by Type
11.4 Central & South America Premenstrual Dysphoric Disorder (PMDD) Market Size by Application

12 International Players Profiles
12.1 Teva
12.1.1 Teva Company Details
12.1.2 Company Description and Business Overview
12.1.3 Premenstrual Dysphoric Disorder (PMDD) Introduction
12.1.4 Teva Revenue in Premenstrual Dysphoric Disorder (PMDD) Business (2014-2019))
12.1.5 Teva Recent Development
12.2 Eli Liliy
12.2.1 Eli Liliy Company Details
12.2.2 Company Description and Business Overview
12.2.3 Premenstrual Dysphoric Disorder (PMDD) Introduction
12.2.4 Eli Liliy Revenue in Premenstrual Dysphoric Disorder (PMDD) Business (2014-2019)
12.2.5 Eli Liliy Recent Development
12.3 Pfizer
12.3.1 Pfizer Company Details
12.3.2 Company Description and Business Overview
12.3.3 Premenstrual Dysphoric Disorder (PMDD) Introduction
12.3.4 Pfizer Revenue in Premenstrual Dysphoric Disorder (PMDD) Business (2014-2019)
12.3.5 Pfizer Recent Development
12.4 Bayer
12.4.1 Bayer Company Details
12.4.2 Company Description and Business Overview
12.4.3 Premenstrual Dysphoric Disorder (PMDD) Introduction
12.4.4 Bayer Revenue in Premenstrual Dysphoric Disorder (PMDD) Business (2014-2019)
12.4.5 Bayer Recent Development
12.5 GSK
12.5.1 GSK Company Details
12.5.2 Company Description and Business Overview
12.5.3 Premenstrual Dysphoric Disorder (PMDD) Introduction
12.5.4 GSK Revenue in Premenstrual Dysphoric Disorder (PMDD) Business (2014-2019)
12.5.5 GSK Recent Development
12.6 Apotex
12.6.1 Apotex Company Details
12.6.2 Company Description and Business Overview
12.6.3 Premenstrual Dysphoric Disorder (PMDD) Introduction
12.6.4 Apotex Revenue in Premenstrual Dysphoric Disorder (PMDD) Business (2014-2019)
12.6.5 Apotex Recent Development
12.7 Bristol Laboratories
12.7.1 Bristol Laboratories Company Details
12.7.2 Company Description and Business Overview
12.7.3 Premenstrual Dysphoric Disorder (PMDD) Introduction
12.7.4 Bristol Laboratories Revenue in Premenstrual Dysphoric Disorder (PMDD) Business (2014-2019)
12.7.5 Bristol Laboratories Recent Development
12.8 Mylan
12.8.1 Mylan Company Details
12.8.2 Company Description and Business Overview
12.8.3 Premenstrual Dysphoric Disorder (PMDD) Introduction
12.8.4 Mylan Revenue in Premenstrual Dysphoric Disorder (PMDD) Business (2014-2019)
12.8.5 Mylan Recent Development
12.9 Allergan
12.9.1 Allergan Company Details
12.9.2 Company Description and Business Overview
12.9.3 Premenstrual Dysphoric Disorder (PMDD) Introduction
12.9.4 Allergan Revenue in Premenstrual Dysphoric Disorder (PMDD) Business (2014-2019)
12.9.5 Allergan Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Product (2019-2025)
13.2 Market Size Forecast by Application (2019-2025)
13.3 Market Size Forecast by Regions
13.4 North America
13.5 Europe
13.6 China
13.7 Japan
13.8 Southeast Asia
13.9 India
13.10 Central & South America

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Premenstrual Dysphoric Disorder (PMDD) Key Market Segments
Table Key Players Premenstrual Dysphoric Disorder (PMDD) Covered
Table Global Premenstrual Dysphoric Disorder (PMDD) Market Size Growth Rate by Type 2018-2025 (Million US$)
Figuer Table Product Figures
Table Key Players of Table Product
Figuer Inject Product Figures
Table Key Players of Inject Product
Figuer Others Figures
Table Key Players of Others
Table Global Premenstrual Dysphoric Disorder (PMDD) Market Size Growth by Application 2019-2025 (Million US$)
Figure Global Premenstrual Dysphoric Disorder (PMDD) Market Share by Application in 2018 & 2025
Figure Hospital Case Studies
Figure Clinic Case Studies
Figure Others Case Studies
Figure Premenstrual Dysphoric Disorder (PMDD) Report Years Considered
Figure Global Premenstrual Dysphoric Disorder (PMDD) Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Premenstrual Dysphoric Disorder (PMDD) Market Size by Regions 2019-2025 (Million US$)
Table Global Premenstrual Dysphoric Disorder (PMDD) Market Size by Regions 2019-2025 (Million US$)
Table Global Premenstrual Dysphoric Disorder (PMDD) Market Share by Regions 2014-2019
Figure Global Premenstrual Dysphoric Disorder (PMDD) Market Share by Regions 2014-2019
Figure Global Premenstrual Dysphoric Disorder (PMDD) Market Share by Regions in 2018
Table Market Top Trends
Table Key Drivers: Impact Analysis (2019-2025)
Table Key Challenges
Figure PORTER'S FIVE FORCES ANALYSIS
Table Global Premenstrual Dysphoric Disorder (PMDD) Revenue by by Players (2014-2019) (Million US$)
Table Global Premenstrual Dysphoric Disorder (PMDD) Market Share by by Players (2014-2019)
Figure Global Premenstrual Dysphoric Disorder (PMDD) Market Share by by Players in 2018
Table Global Premenstrual Dysphoric Disorder (PMDD) by Players Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Premenstrual Dysphoric Disorder (PMDD) Product/Solution/Service
Table Date of Enter into Premenstrual Dysphoric Disorder (PMDD) Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Premenstrual Dysphoric Disorder (PMDD) Market Size by Type (2014-2019) (Million US$)
Table Global Premenstrual Dysphoric Disorder (PMDD) Market Size Share by Type (2014-2019)
Figure Global Premenstrual Dysphoric Disorder (PMDD) Market Size Market Share by Type (2014-2019)
Table Global Premenstrual Dysphoric Disorder (PMDD) Market Size by Application (2014-2019) (Million US$)
Table Global Premenstrual Dysphoric Disorder (PMDD) Market Size Share by Application (2014-2019)
Figure Global Premenstrual Dysphoric Disorder (PMDD) Market Size Market Share by Application (2014-2019)
Figure Global Premenstrual Dysphoric Disorder (PMDD) Revenue Market Share by Application in 2018
Figure North America Premenstrual Dysphoric Disorder (PMDD) Market Size 2014-2019 (Million US$)
Table North America Key Players Premenstrual Dysphoric Disorder (PMDD) Revenue (2018-2019) (Million US$)
Table North America Key Players Premenstrual Dysphoric Disorder (PMDD) Market Share (2018-2019)
Table North America Premenstrual Dysphoric Disorder (PMDD) Market Size by Type 2014-2019 (Million US$)
Table North America Premenstrual Dysphoric Disorder (PMDD) Market Share by Type 2014-2019
Table North America Premenstrual Dysphoric Disorder (PMDD) Market Size by Application 2014-2019 (Million US$)
Table North America Premenstrual Dysphoric Disorder (PMDD) Market Share by Application 2014-2019
Figure Europe Premenstrual Dysphoric Disorder (PMDD) Market Size 2014-2019 (Million US$)
Table Europe Key Players Premenstrual Dysphoric Disorder (PMDD) Revenue (2018-2019) (Million US$)
Table Europe Key Players Premenstrual Dysphoric Disorder (PMDD) Market Share (2018-2019)
Table Europe Premenstrual Dysphoric Disorder (PMDD) Market Size by Type 2014-2019 (Million US$)
Table Europe Premenstrual Dysphoric Disorder (PMDD) Market Share by Type 2014-2019
Table Europe Premenstrual Dysphoric Disorder (PMDD) Market Size by Application 2014-2019 (Million US$)
Table Europe Premenstrual Dysphoric Disorder (PMDD) Market Share by Application 2014-2019
Figure China Premenstrual Dysphoric Disorder (PMDD) Market Size 2014-2019 (Million US$)
Table China Key Players Premenstrual Dysphoric Disorder (PMDD) Revenue (2018-2019) (Million US$)
Table China Key Players Premenstrual Dysphoric Disorder (PMDD) Market Share (2018-2019)
Table China Premenstrual Dysphoric Disorder (PMDD) Market Size by Type 2014-2019 (Million US$)
Table China Premenstrual Dysphoric Disorder (PMDD) Market Share by Type 2014-2019
Table China Premenstrual Dysphoric Disorder (PMDD) Market Size by Application 2014-2019 (Million US$)
Table China Premenstrual Dysphoric Disorder (PMDD) Market Share by Application 2014-2019
Figure Japan Premenstrual Dysphoric Disorder (PMDD) Market Size 2014-2019 (Million US$)
Table Japan Key Players Premenstrual Dysphoric Disorder (PMDD) Revenue (2018-2019) (Million US$)
Table Japan Key Players Premenstrual Dysphoric Disorder (PMDD) Market Share (2018-2019)
Table Japan Premenstrual Dysphoric Disorder (PMDD) Market Size by Type 2014-2019 (Million US$)
Table Japan Premenstrual Dysphoric Disorder (PMDD) Market Share by Type 2014-2019
Table Japan Premenstrual Dysphoric Disorder (PMDD) Market Size by Application 2014-2019 (Million US$)
Table Japan Premenstrual Dysphoric Disorder (PMDD) Market Share by Application 2014-2019
Figure Southeast Asia Premenstrual Dysphoric Disorder (PMDD) Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Premenstrual Dysphoric Disorder (PMDD) Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Premenstrual Dysphoric Disorder (PMDD) Market Share (2018-2019)
Table Southeast Asia Premenstrual Dysphoric Disorder (PMDD) Market Size by Type 2014-2019 (Million US$)
Table Southeast Asia Premenstrual Dysphoric Disorder (PMDD) Market Share by Type 2014-2019
Table Southeast Asia Premenstrual Dysphoric Disorder (PMDD) Market Size by Application 2014-2019 (Million US$)
Table Southeast Asia Premenstrual Dysphoric Disorder (PMDD) Market Share by Application 2014-2019
Figure India Premenstrual Dysphoric Disorder (PMDD) Market Size 2014-2019 (Million US$)
Table India Key Players Premenstrual Dysphoric Disorder (PMDD) Revenue (2018-2019) (Million US$)
Table India Key Players Premenstrual Dysphoric Disorder (PMDD) Market Share (2018-2019)
Table India Premenstrual Dysphoric Disorder (PMDD) Market Size by Type 2014-2019 (Million US$)
Table India Premenstrual Dysphoric Disorder (PMDD) Market Share by Type 2014-2019
Table India Premenstrual Dysphoric Disorder (PMDD) Market Size by Application 2014-2019 (Million US$)
Table India Premenstrual Dysphoric Disorder (PMDD) Market Share by Application 2014-2019
Figure Central & South America Premenstrual Dysphoric Disorder (PMDD) Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Premenstrual Dysphoric Disorder (PMDD) Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Premenstrual Dysphoric Disorder (PMDD) Market Share (2018-2019)
Table Central & South America Premenstrual Dysphoric Disorder (PMDD) Market Size by Type 2014-2019 (Million US$)
Table Central & South America Premenstrual Dysphoric Disorder (PMDD) Market Share by Type 2014-2019
Table Central & South America Premenstrual Dysphoric Disorder (PMDD) Market Size by Application 2014-2019 (Million US$)
Table Central & South America Premenstrual Dysphoric Disorder (PMDD) Market Share by Application 2014-2019
Table Teva Company Details
Table Teva Revenue in Premenstrual Dysphoric Disorder (PMDD) Business 2014-2019 (Million US$)
Figure Teva Revenue Growth Rate in Premenstrual Dysphoric Disorder (PMDD) Business (2014-2019)
Table Teva Recent Development
Table Eli Liliy Company Details
Table Eli Liliy Revenue in Premenstrual Dysphoric Disorder (PMDD) Business 2014-2019 (Million US$)
Figure Eli Liliy Revenue Growth Rate in Premenstrual Dysphoric Disorder (PMDD) Business (2014-2019)
Table Eli Liliy Recent Development
Table Pfizer Company Details
Table Pfizer Revenue in Premenstrual Dysphoric Disorder (PMDD) Business 2014-2019 (Million US$)
Figure Pfizer Revenue Growth Rate in Premenstrual Dysphoric Disorder (PMDD) Business (2014-2019)
Table Pfizer Recent Development
Table Bayer Company Details
Table Bayer Revenue in Premenstrual Dysphoric Disorder (PMDD) Business 2014-2019 (Million US$)
Figure Bayer Revenue Growth Rate in Premenstrual Dysphoric Disorder (PMDD) Business (2014-2019)
Table Bayer Recent Development
Table GSK Company Details
Table GSK Revenue in Premenstrual Dysphoric Disorder (PMDD) Business 2014-2019 (Million US$)
Figure GSK Revenue Growth Rate in Premenstrual Dysphoric Disorder (PMDD) Business (2014-2019)
Table GSK Recent Development
Table Apotex Company Details
Table Apotex Revenue in Premenstrual Dysphoric Disorder (PMDD) Business 2014-2019 (Million US$)
Figure Apotex Revenue Growth Rate in Premenstrual Dysphoric Disorder (PMDD) Business (2014-2019)
Table Apotex Recent Development
Table Bristol Laboratories Company Details
Table Bristol Laboratories Revenue in Premenstrual Dysphoric Disorder (PMDD) Business 2014-2019 (Million US$)
Figure Bristol Laboratories Revenue Growth Rate in Premenstrual Dysphoric Disorder (PMDD) Business (2014-2019)
Table Bristol Laboratories Recent Development
Table Mylan Company Details
Table Mylan Revenue in Premenstrual Dysphoric Disorder (PMDD) Business 2014-2019 (Million US$)
Figure Mylan Revenue Growth Rate in Premenstrual Dysphoric Disorder (PMDD) Business (2014-2019)
Table Mylan Recent Development
Table Allergan Company Details
Table Allergan Revenue in Premenstrual Dysphoric Disorder (PMDD) Business 2014-2019 (Million US$)
Figure Allergan Revenue Growth Rate in Premenstrual Dysphoric Disorder (PMDD) Business (2014-2019)
Table Allergan Recent Development
Table Global Premenstrual Dysphoric Disorder (PMDD) Market Size by Regions (Million US$) 2019-2025
Figure Global Premenstrual Dysphoric Disorder (PMDD) Market Size Share by Regions (2019-2025)
Figure Global Premenstrual Dysphoric Disorder (PMDD) Market Size Share by Regions in 2025
Figure North America Premenstrual Dysphoric Disorder (PMDD) Market Size Forecast (2019-2025)(Million USD)
Figure Europe Premenstrual Dysphoric Disorder (PMDD) Market Size Forecast (2019-2025)(Million USD)
Figure China Premenstrual Dysphoric Disorder (PMDD) Market Size Forecast (2019-2025)(Million USD)
Figure Japan Premenstrual Dysphoric Disorder (PMDD) Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Premenstrual Dysphoric Disorder (PMDD) Market Size Forecast (2019-2025)(Million USD)
Figure India Premenstrual Dysphoric Disorder (PMDD) Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Premenstrual Dysphoric Disorder (PMDD) Market Size Forecast (2019-2025)(Million USD)
Table Global Premenstrual Dysphoric Disorder (PMDD) Market Size by Product (2019-2025) (Million US$)
Figure Global Premenstrual Dysphoric Disorder (PMDD) Market Size by Product (2019-2025)
Figure Global Premenstrual Dysphoric Disorder (PMDD) Market Size by Product in 2025
Table Global Premenstrual Dysphoric Disorder (PMDD) Market Size by Application (2019-2025) (Million US$)
Figure Global Premenstrual Dysphoric Disorder (PMDD) Market Size by Application (2019-2025)
Figure Global Premenstrual Dysphoric Disorder (PMDD) Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

以下、関連資料のご紹介

HPV関連障害のグローバル市場：規模・現状・予測2019-2025

Global HPV Associated Disorder Market Size, Status and Forecast 2019-2025
QYR9NV18014 2019年11月18日 93Pages
※当調査レポートでは、HPV関連障害の世界市場について調査・分析し、HPV関連障害の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（予防、治療）、用途別（病院薬局、小売薬局、オンライン薬局）、地域別（...

HPV関連障害のグローバル市場：規模・現状・予測2019-2025

神経疾患診断のグローバル市場：規模・現状・予測2019-2025

Global Neurological Disorder Diagnostics Market Size, Status and Forecast 2019-2025
QYR9NV18208 2019年11月18日 95Pages
※当調査レポートでは、神経疾患診断の世界市場について調査・分析し、神経疾患診断の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（イメージング技術、体外診断技術）、用途別（病院およびクリニック、診断セン...

強迫性障害治療薬のグローバル市場：規模・現状・予測2019-2025

Global Obsessive-Compulsive Disorder Drugs Market Size, Status and Forecast 2019-2025
QYR9NV18219 2019年11月18日 99Pages
※当調査レポートでは、強迫性障害治療薬の世界市場について調査・分析し、強迫性障害治療薬の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（SSRI、TCA、その他）、用途別（病院、クリニック、研究所、そ...

選択的セロトニン再取り込み阻害薬（SSRI）のグローバル市場：規模・現状・予測2019-2025

Global Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size, Status and Forecast 2019-2025
QYR9NV18407 2019年11月18日 99Pages
※当調査レポートでは、選択的セロトニン再取り込み阻害薬（SSRI）の世界市場について調査・分析し、選択的セロトニン再取り込み阻害薬（SSRI）の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（シタロプ...

心的外傷後ストレス障害治療法のグローバル市場：規模・現状・予測2019-2025

Global Post-Traumatic Stress Disorder Therapeutics Market Size, Status and Forecast 2019-2025
QYR9NV18306 2019年11月18日 97Pages
※当調査レポートでは、心的外傷後ストレス障害治療法の世界市場について調査・分析し、心的外傷後ストレス障害治療法の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（抗うつ薬、抗不安薬、その他）、用途別（病...

出荷前検査（PSI）のグローバル市場：規模・現状・予測2019-2025

Global Pre-Shipment Inspection (PSI) Market Size, Status and Forecast 2019-2025
QYR9NV18312 2019年11月18日 93Pages
※当調査レポートでは、出荷前検査（PSI）の世界市場について調査・分析し、出荷前検査（PSI）の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（社内、外部委託）、用途別（海上輸送、道路輸送、航空輸送）...

タービン応力評価装置(TSE)のグローバル市場：規模・現状・予測2019-2025

Global Turbine Stress Evaluator (TSE) Market Size, Status and Forecast 2019-2025
QYR9NV18513 2019年11月18日 95Pages
※当調査レポートでは、タービン応力評価装置(TSE)の世界市場について調査・分析し、タービン応力評価装置(TSE)の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（ハードウェア、ソフトウェア）、用途別...

総合設備管理（IFM）のグローバル市場：規模・現状・予測2019-2025

Global Integrated Facilities Management (IFM) Market Size, Status and Forecast 2019-2025
QYR9NV18040 2019年11月18日 92Pages
※当調査レポートでは、総合設備管理（IFM）の世界市場について調査・分析し、総合設備管理（IFM）の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（資産及びスペース管理、プロジェクト管理、不動産ポート...

垂直産業向け人工知能(AI)のグローバル市場：規模・現状・予測2019-2025

Global Artificial Intelligence (AI) Verticals Market Size, Status and Forecast 2019-2025
QYR9NV17637 2019年11月18日 91Pages
※当調査レポートでは、垂直産業向け人工知能(AI)の世界市場について調査・分析し、垂直産業向け人工知能(AI)の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（自動運転、機械学習、データマイニング、そ...

強迫性障害治療薬のグローバル市場：規模・現状・予測2019-2025 Obsessive–compulsive disorder (OCD) is a mental disorder in which a person feels the need to perform certain routines repeatedly (called "compulsions"), or has certain thoughts repeatedly (called "obsessions").The launch of new molecules is one of the primary drivers for the obsessive-compulsive dis…
HPV関連障害のグローバル市場：規模・現状・予測2019-2025 HPV Associated Disorder means a series of diseases associated with HPV, either pre-disease or some of the diseases induced thereby.In 2018, the global HPV Associated Disorder market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-…
HPV関連障害のグローバル市場：規模・現状・予測2019-2025 HPV Associated Disorder means a series of diseases associated with HPV, either pre-disease or some of the diseases induced thereby.In 2018, the global HPV Associated Disorder market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-…
神経疾患診断のグローバル市場：規模・現状・予測2019-2025 Neurological disorders diagnostic tools are tools used to diagnose various neurological disorders.In 2018, the global Neurological Disorder Diagnostics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focus…
心的外傷後ストレス障害治療法のグローバル市場：規模・現状・予測2019-2025 The main treatments for post-traumatic stress disorder (PTSD) are psychological therapies and medication.In 2018, the global Post-Traumatic Stress Disorder Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. …